Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Rule 425 Communication · 425

ASP Isotopes Inc.

ASPINASDAQEQUITYCurrent

Rule 425 Communication

Filed Aug 21, 2026Accepted Aug 20, 2026, 8:22 PM EDTCIK 1921865Accession 0001477932-26-005199
Share

Company context

ASP Isotopes is developing a differentiated isotope enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy. The Company’s proprietary technologies, the Aerodynamic Separation Process (“ASP technology”) and Quantum Enrichment (“QE technology”), are designed to enable the production of isotopes for a range of industrial and advanced technology applications. ASP Isotopes operates isotope enrichment facilities in Pretoria, South Africa, focused on the enrichment of low atomic mass elements, or light isotopes. For more information, please visit www.aspisotopes.com.

Current securities

Recent company filings

  1. 144 filingSep 25, 2026
  2. 425 filingSep 9, 2026
  3. 425 filingSep 9, 2026
  4. Regulation FD DisclosureSep 8, 2026
  5. 4 filingSep 4, 2026

As-filed source

Primary evidence